ArticleInternational urogynecology journal2026
The Long-Term Effectiveness of Fractional CO
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisTo evaluate the long-term effectiveness of fractional CO
methodsThis retrospective cohort study included 215 women with clinically diagnosed SUI who underwent a standardized course of fractional CO
resultsSignificant improvement was observed throughout follow-up in all primary and secondary outcomes (p = 0.0001). Satisfaction scores increased significantly at 4-6 weeks compared to baseline and still exhibited a high level at 1 year. Although a partial decrease occurred in the second year, values still remained significantly above baseline (from median 2 to 4; p = 0.0001). MISI decreased from 19.51 ± 4.41 at baseline to 1.96 ± 1.38 at 4-6 weeks. Although values rose to 6.31 ± 4.01 in the second year, significant improvement compared to baseline was maintained (p = 0.0001). Significant improvement was observed in all FSFI subdomains (including desire, arousal, lubrication, orgasm, satisfaction, pain, and total score) in the early period (p = 0.0001), and despite a slight decrease in the second year, the gains were largely maintained. Similar marked improvements were also observed in VSQ and FGSIS scores, with no return to baseline values despite a partial decline in the second year (p = 0.0001). Supportive additional session requirements were determined in association with subjective worsening in symptoms in the second year in approximately 20% of the participants.
conclusionsFractional CO
Indexed as
Identifiers
41863560What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.